During the past decade, Allergy and Asthma Research NJ inc conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Allergy and Asthma Research NJ inc" are "Asthma" (2 trials), "Perennial Allergic Rhinitis" (2 trials) and "Seasonal Allergic Rhinitis" (2 trials). Many other conditions were trialed in "Allergy and Asthma Research NJ inc" in a lesser frequency.

Most popular intervention types in "Allergy and Asthma Research NJ inc" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "0.15% azelastine hydrochloride" (2 trials), "Placebo" (2 trials), "0.1% azelastine hydrochloride" (1 trials), "0.15% azelastine hydrochloride Nasal Spray" (1 trials) and "Dymista vehicle" (1 trials). Other intervention names were less common.

The vast majority of trials in "Allergy and Asthma Research NJ inc" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Allergy and Asthma Research NJ inc". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Allergy and Asthma Research NJ inc, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Allergy and Asthma Research NJ inc, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".